Delivra Health Brands Inc. (TSXV:DHB)
Canada · Delayed Price · Currency is CAD 0.2050
0.00 (0.00%)
At close: Jan 20, 2026
Delivra Health Brands Income Statement
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
| 13.41 | 13.37 | 12.38 | 9.79 | 8.14 | 7.96 | Upgrade | |
Revenue Growth (YoY) | 13.01% | 8.01% | 26.42% | 20.30% | 2.30% | 2.24% | Upgrade |
Cost of Revenue | 6.73 | 6.59 | 5.98 | 4.97 | 5.54 | 6.04 | Upgrade |
Gross Profit | 6.68 | 6.78 | 6.4 | 4.82 | 2.6 | 1.92 | Upgrade |
Selling, General & Admin | 5.91 | 6.07 | 5.77 | 4.7 | 6.15 | 8.31 | Upgrade |
Research & Development | - | - | - | - | - | 0.07 | Upgrade |
Operating Expenses | 7.14 | 7.62 | 7.11 | 6.19 | 8.62 | 11.18 | Upgrade |
Operating Income | -0.46 | -0.84 | -0.71 | -1.36 | -6.01 | -9.26 | Upgrade |
Interest Expense | -0.12 | -0.12 | -0.17 | -0.25 | -0.64 | - | Upgrade |
Interest & Investment Income | - | - | - | - | - | 0.04 | Upgrade |
Currency Exchange Gain (Loss) | -0.12 | -0.12 | -0.07 | -0.05 | 0.01 | 0 | Upgrade |
EBT Excluding Unusual Items | -0.7 | -1.08 | -0.94 | -1.67 | -6.64 | -9.22 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | -0.02 | 0.49 | -0.6 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -0.04 | 0.6 | -0.69 | -0.24 | Upgrade |
Asset Writedown | - | - | - | - | -0.4 | -12.11 | Upgrade |
Other Unusual Items | -0.1 | -0.11 | 1.86 | 0.9 | 0.23 | -0.5 | Upgrade |
Pretax Income | -0.8 | -1.19 | 0.88 | -0.18 | -7.01 | -22.67 | Upgrade |
Earnings From Continuing Operations | -0.8 | -1.19 | 0.88 | -0.18 | -7.01 | -22.67 | Upgrade |
Earnings From Discontinued Operations | - | - | - | - | - | -5.87 | Upgrade |
Net Income to Company | -0.8 | -1.19 | 0.88 | -0.18 | -7.01 | -28.54 | Upgrade |
Net Income | -0.8 | -1.19 | 0.88 | -0.18 | -7.01 | -28.54 | Upgrade |
Net Income to Common | -0.8 | -1.19 | 0.88 | -0.18 | -7.01 | -28.54 | Upgrade |
Shares Outstanding (Basic) | 32 | 31 | 29 | 25 | 25 | 23 | Upgrade |
Shares Outstanding (Diluted) | 32 | 31 | 29 | 25 | 25 | 23 | Upgrade |
Shares Change (YoY) | 6.03% | 9.44% | 13.08% | - | 11.80% | 5.06% | Upgrade |
EPS (Basic) | -0.03 | -0.04 | 0.03 | -0.01 | -0.28 | -1.26 | Upgrade |
EPS (Diluted) | -0.03 | -0.04 | 0.03 | -0.01 | -0.28 | -1.26 | Upgrade |
Free Cash Flow | -0.68 | -0.75 | 0.76 | -1.09 | -4.45 | -9.68 | Upgrade |
Free Cash Flow Per Share | -0.02 | -0.02 | 0.03 | -0.04 | -0.18 | -0.43 | Upgrade |
Gross Margin | 49.81% | 50.70% | 51.70% | 49.26% | 31.99% | 24.12% | Upgrade |
Operating Margin | -3.41% | -6.29% | -5.74% | -13.92% | -73.87% | -116.39% | Upgrade |
Profit Margin | -5.99% | -8.90% | 7.08% | -1.88% | -86.12% | -358.70% | Upgrade |
Free Cash Flow Margin | -5.05% | -5.64% | 6.11% | -11.11% | -54.69% | -121.67% | Upgrade |
EBITDA | 0.51 | 0.43 | 0.6 | -0.03 | -3.94 | -7.04 | Upgrade |
EBITDA Margin | 3.82% | 3.19% | 4.84% | -0.34% | -48.42% | -88.54% | Upgrade |
D&A For EBITDA | 0.97 | 1.27 | 1.31 | 1.33 | 2.07 | 2.22 | Upgrade |
EBIT | -0.46 | -0.84 | -0.71 | -1.36 | -6.01 | -9.26 | Upgrade |
EBIT Margin | -3.41% | -6.29% | -5.74% | -13.92% | -73.87% | -116.39% | Upgrade |
Revenue as Reported | - | - | - | 9.79 | 8.14 | 7.96 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.